GlassScriptPhysician profile
Crystal Ayala
NPI 1790266781
$3,996.89
in general payments reported to CMS, 2019-2025
25 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.01 · 2022: $85.94 · 2023: $1,227 · 2024: $1,490 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,893.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $623.88 | 2024-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Selectsecure |
| Novartis Pharmaceuticals Corporation | $434.63 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $348.57 | 2023-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $343.04 | 2023-2025 | Amvuttra, Onpattro |
| Edwards Lifesciences Corporation | $268.91 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $254.17 | 2023-2025 | |
| Novo Nordisk INC | $237.32 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $226.01 | 2023-2025 | Verquvo |
| Boston Scientific Corporation | $212.42 | 2024-2025 | Bodyguardian, Latitude Communicator Power Supply |
| Cvrx, INC. | $164.19 | 2024-2025 | Barostim Neo System |
| Atricure, INC. | $134.23 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.12 | 2022-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $93.48 | 2025 | Assure Wcd |
| Abbott Laboratories | $90.95 | 2023 | Ensite Precision |
| Astrazeneca Pharmaceuticals LP | $88.84 | 2021-2025 | Farxiga |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $88.10 | 2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $76.46 | 2024 | |
| Inspire Medical Systems, INC. | $44.27 | 2024-2025 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $37.51 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.87 | 2024-2025 | Jardiance |
| Baxter Healthcare | $21.72 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $20.91 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $16.16 | 2025 | Shingrix, Arexvy |
| Lantheus Medical Imaging, INC. | $15.75 | 2024 | |
| Scpharmaceuticals INC. | $14.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Ayala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.